2nd Quarter - Report

ASCENDIS PHARMA, LLC for ASCENDIS PHARMA, LLC

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Rare disease issues. Orphan drugs. Prescription Drug User Fee (PDUFA) reauthorization.

Foreign entity interest: Ascendis Pharma, Inc. is wholly-owned by Ascendis Pharma A/S, and its interests in relation to these issues are similar to those of Ascendis Pharma, Inc.

LobbyistCovered position, as disclosed
CARY T GIBSON —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.